RecruitingNCT05440214
Targeting Emotion Dysregulation to Reduce Suicide in People With Psychosis
What is this study about?
In BaltimoreThis study assesses suicidal thoughts.
SchizophreniaBehavioural studyAges 18+
Study directory
Back to overviewSchizophrenia studies
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
RecruitingNCT05131035
Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis Risk
Official study title
In Glen OaksTargeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis Risk in Adolescents at Clinical High Risk for Psychosis
SchizophreniaBehavioural studyAges 14–20
RecruitingNCT05968560
Telehealth Cognitive Behavioral Therapy for Youth at Risk for Psychosis
Official study title
In New YorkTelehealth Adaptation of Group and Family-Based Cognitive Behavioral Therapy for Youth at Risk for Psychosis
SchizophreniaBehavioural studyAges 14–25
RecruitingNCT06651112
The ATP Project (Antipsychotic-TEP-Psychosis)
Official study title
In SherbrookeImpacts of Psychosis and Antipsychotics on Cerebral Energy Metabolism: the ATP Project (Antipsychotic-TEP-Psychosis)
SchizophreniaObservational studyAges 18–35
RecruitingACTRN12624001303538
The CanOPY Study: The efficacy of cannabidiol in addition to standard treatment in first episode psychosis in young people
Official study title
In AustraliaThe efficacy of cannabidiol adjunct to standard treatment in reducing positive psychotic symptoms in young people with first episode psychosis
SchizophreniaInterventional studyAges 15–25
RecruitingACTRN12606000101583
The DEPTH Project: Detection, Evaluation, and Psychological Therapy for Health
Official study title
Location not clearly listedRandomised controlled trial of cognitive behaviour therapy to prevent psychosis among people with at-risk mental states
SchizophreniaInterventional studyAges 12–30
RecruitingISRCTN16495294
Translating evidence for early intervention in psychosis (TRANSLATE) in low and lower-middle countries (LMIC): implementation and evaluation
In PakistanSchizophreniaResearch studyAges 18–35
RecruitingNCT05763966
Uppsala Psychosis Cohort
Official study title
In UppsalaUppsala Psychosis Cohort: a Multimodal Study in Early Stage Psychosis Patients, High Risk Individuals and Healthy Controls
SchizophreniaObservational studyAges 18–40
RecruitingNCT06728241
Virtual Reality and Artificial Intelligence in Treatment for people with Psychosis
Official study title
In OsloRecoVRy - A Randomized Controlled Trial Examining the Effect of Artificial Intelligence Powered Virtual Reality Treatment in Psychosis
SchizophreniaBehavioural studyAges 17–65
RecruitingEUCTR 2021-000350-26
A double blind, randomized, placebo-controlled, adaptive 24-week Phase IIb trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia....
This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.
Multiple locations, including KazanlikSchizophreniaHistorical research record
RecruitingEUCTR 2017-001170-42
An adaptive Phase II/III, Double-Blind, Randomized, Placebo-controlled, Two-Part, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase In...
This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.
Multiple locations, including GdańskSchizophreniaHistorical research record
RecruitingEUCTR 2021-001333-38
Cognitive effects of adjuntive Vortioxetine in early Schizophrenia
This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.
In SevillaSchizophreniaHistorical research record
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.